Transforming growth factor-beta 1 produced by vascular smooth muscle cells predicts fibrosis in the gastrocnemius of patients with peripheral artery disease

被引:43
作者
Ha, Duy M. [1 ,2 ]
Carpenter, Lauren C. [1 ]
Koutakis, Panagiotis [1 ]
Swanson, Stanley A. [1 ]
Zhu, Zhen [1 ]
Hanna, Mina [2 ]
DeSpiegelaere, Holly K. [3 ,4 ]
Pipinos, Iraklis I. [1 ,2 ,3 ,4 ,6 ]
Casale, George P. [1 ,5 ]
机构
[1] Univ Nebraska Med Ctr, Dept Surg, Omaha, NE USA
[2] Univ Nebraska Med Ctr, Dept Cellular & Integrat Physiol, Omaha, NE USA
[3] VA Nebraska Western Iowa Hlth Care Syst, Dept Surg, Omaha, NE USA
[4] VA Nebraska Western Iowa Hlth Care Syst, VA Res Serv, Omaha, NE USA
[5] 987690 Nebraska Med Ctr, Omaha, NE 68198 USA
[6] 983280 Nebraska Med Ctr, Omaha, NE 68198 USA
关键词
Peripheral artery disease; Skeletal muscle; Fibrosis; Transforming growth factor-beta 1; Vascular smooth muscle cells; Microvasculature; SKELETAL-MUSCLE; OXIDATIVE DAMAGE; RISK-FACTORS; TGF-BETA; PROLIFERATION; MECHANISMS; GROWTH-FACTOR-BETA-1; ARTERIOLIZATION; ACCUMULATION; EXPRESSION;
D O I
10.1186/s12967-016-0790-3
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Lower leg ischemia, myopathy, and limb dysfunction are distinguishing features of peripheral artery disease (PAD). The myopathy of PAD is characterized by myofiber degeneration in association with extracellular matrix expansion, and increased expression of transforming growth factor-beta 1 (TGF-beta 1; a pro-fibrotic cytokine). In this study, we evaluated cellular expression of TGF-beta 1 in gastrocnemius of control (CTRL) and PAD patients and its relationship to deposited collagen, fibroblast accumulation and limb hemodynamics. Methods: Gastrocnemius biopsies were collected from PAD patients with claudication (PAD-II; N = 25) and tissue loss (PAD-IV; N = 20) and from CTRL patients (N = 20). TGF-beta 1 in slide-mounted specimens was labeled with fluorescent antibodies and analyzed by quantitative wide-field, fluorescence microscopy. We evaluated co-localization of TGF-beta 1 with vascular smooth muscle cells (SMC) (high molecular weight caldesmon), fibroblasts (TE-7 antigen), macrophages (CD163), T cells (CD3) and endothelial cells (CD31). Collagen was stained with Masson Trichrome and collagen density was determined by quantitative bright-field microscopy with multi-spectral imaging. Results: Collagen density increased from CTRL to PAD-II to PAD-IV specimens (all differences p < 0.05) and was prominent around microvessels. TGF-beta 1 expression increased with advancing disease (all differences p < 0.05), correlated with collagen density across all specimens (r = 0.864; p < 0.001), associated with fibroblast accumulation, and was observed exclusively in SMC. TGF-beta 1 expression inversely correlated with ankle-brachial index across PAD patients (r = -0.698; p < 0.001). Conclusions: Our findings support a progressive fibrosis in the gastrocnemius of PAD patients that is caused by elevated TGF-beta 1 production in the SMC of microvessels in response to tissue hypoxia.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] The levels of transforming growth factor-beta 1 are increased in the serum of patients with psoriasis and correlate with disease severity
    Bonifati, C
    Carducci, M
    Mussi, A
    Pittarello, A
    DAgosto, G
    Fazio, M
    Ameglio, F
    EUROPEAN JOURNAL OF DERMATOLOGY, 1996, 6 (07) : 486 - 490
  • [22] Profile of transforming growth factor-beta 1 in patients with dengue haemorrhagic fever
    Agarwal, R
    Elbishbishi, EA
    Chaturvedi, UC
    Nagar, R
    Mustafa, AS
    INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 1999, 80 (03) : 143 - 149
  • [23] The role of transforming growth factor-beta 1 (TGF-beta 1) and of vascular endothelial growth factor (VEGF) on the in vitro angiogenesis process
    Vailhe, B
    Tranqui, L
    COMPTES RENDUS DE L ACADEMIE DES SCIENCES SERIE III-SCIENCES DE LA VIE-LIFE SCIENCES, 1996, 319 (11): : 1003 - 1010
  • [24] Transforming Growth Factor-Beta 3 Alters Intestinal Smooth Muscle Function: Implications for Gastroschisis-Related Intestinal Dysfunction
    Moore-Olufemi, S. D.
    Olsen, A. B.
    Hook-Dufresne, D. M.
    Bandla, V.
    Cox, C. S., Jr.
    DIGESTIVE DISEASES AND SCIENCES, 2015, 60 (05) : 1206 - 1214
  • [25] Podocyte injury and overexpression of vascular endothelial growth factor and transforming growth factor-beta 1 in adriamycin-induced nephropathy in rats
    Yang, Weina
    Wang, Junjian
    Shi, Lili
    Yu, Linhua
    Qian, Yihua
    Liu, Yong
    Wang, Weixi
    Cheng, Shaoli
    CYTOKINE, 2012, 59 (02) : 370 - 376
  • [26] Transforming growth factor-beta 1 or ascorbic acid are able to differentiate Wharton's jelly mesenchymal stem cells towards a smooth muscle phenotype
    Mesure, B.
    Huber-Villaume, S.
    Menu, P.
    Velot, E.
    BIO-MEDICAL MATERIALS AND ENGINEERING, 2017, 28 : S101 - S105
  • [27] Circulating transforming growth factor beta 1 and coronary artery disease
    Wang, XL
    Liu, SX
    Wilcken, DEL
    CARDIOVASCULAR RESEARCH, 1997, 34 (02) : 404 - 410
  • [28] The expression of transforming growth factor-beta s and TGF-beta receptor mRNA and protein and the effect of TGF-beta s on human myometrial smooth muscle cells in vitro
    Tang, XM
    Dou, QC
    Zhao, Y
    McLean, F
    Davis, J
    Chegini, N
    MOLECULAR HUMAN REPRODUCTION, 1997, 3 (03) : 233 - 240
  • [29] Differential regulation of transforming growth factor receptors by angiotensin II and transforming growth factor-β1 in vascular smooth muscle
    Siegert, A
    Ritz, E
    Orth, S
    Wagner, J
    JOURNAL OF MOLECULAR MEDICINE-JMM, 1999, 77 (05): : 437 - 445
  • [30] Differential regulation of transforming growth factor receptors by angiotensin II and transforming growth factor-β1 in vascular smooth muscle
    Antje Siegert
    Eberhard Ritz
    Stefan Orth
    J. Wagner
    Journal of Molecular Medicine, 1999, 77 : 437 - 445